Insiders · Profile

Beyer Russell P

Chief Financial Officer at SAB Biotherapeutics. Filing since 26 Oct 2021. CIK 0001889754

Company

Date

Role

Action

Amount

Of holding

26 Oct 2021

Chief Financial Officer

Sold, plan not stated

278

$2.20K

100%

1 decision on file.